Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation

Volume:9   Issue:8
Pp: 888-903
A. Carpi, A. Nicolini, A. Antonelli, P. Ferrari and G. Rossi
DOI: 10.2174/156800909790192392

Order Reprints Order Eprints

Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer

Volume:9   Issue:8
Pp: 904-914
J. Bielanska, J. Hernandez-Losa, M. Perez-Verdaguer, T. Moline, R. Somoza, S. Ramon y Cajal, E. Condom, J. C. Ferreres and A. Felipe
DOI: 10.2174/156800909790192400

Order Reprints Order Eprints

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

Volume:9   Issue:8
Pp: 938-952
X. Liu, R. C. Newton, S. M. Friedman and P. A. Scherle
DOI: 10.2174/156800909790192374

Order Reprints Order Eprints

Poly(ADP-ribose) Glycohydrolase Deficiency Sensitizes Mouse ES Cells to DNA Damaging Agents

Volume:9   Issue:8
Pp: 953-962
H. Fujihara, H. Ogino, D. Maeda, H. Shirai, T. Nozaki, N. Kamada, K. Jishage, S. Tanuma, T. Takato, T. Ochiya, T. Sugimura and M. Masutani
DOI: 10.2174/156800909790192419

Order Reprints Order Eprints